Tip:
Highlight text to annotate it
X
Good morning. My name is Dr. Mo and I headed up the healthcare
team at the National Broadband Plan of the FCC.
If you remember, in part of the plan, we suggested that the FCC have a joint workshop with the
FDA to really add some more regulatory transparency in this convergence of telecommunications
in medical devices. Well today, we are having the panel, so as
you can see around me, the range of vendors are setting up.
We've got about 25 very exciting companies showing their solutions.
We have some very large companies, some start ups, some classic telecoms companies, we also
have the classic healthcare companies.
So there's a real diversity in the types of things we can see today.
And what's very interesting is that some of these solutions aim for providers, and some
of them are aimed at consumers, so I'm hoping we can have a really
good idea of what's out there in terms of innovation.
So, why don't we take a look around and see what they're showing.
Broadband enables remote diagnostics in healthcare, that can allow patients in the most isolated
parts of America to receive care from the very best specialists
thousands of miles away. Broadband enables remote medical monitoring.
Wireless devices can help diabetes patients track their glucose levels.
Or heart disease patients monitor their cardiovascular data.
Broadband can enable widespread access to electronic health records, wherever the patient
may be, and save our nation more than 500 billion dollars over
the next 15 years. When a patient has a change in their heart
rate or rhythm, it automatically triggers the phone to send the data to
our clinical monitor center. We've essentially created a virtual hospital.
When there's approximately 400 cardiac technicians and nurses monitoring patients 24 hours a
day. Do you also find better patient compliance
because this is so much less cumbersome than-? Absolutely. When you have newer generation
technology like this, this auto-detects and auto-sends.
So even if a patient is having a asymptomatic arythmia, such as a five or six second pause
in their heart beat, they won't feel that necessarily all the time.
This device automatically picks that up, it's based upon an algorithm in the sensor, and
sends it to us. The Intel Health Guide, which is our personal
healthcare device, it's a patient's home now, it works on a telephone
line, 3G wireless, or wired broadband. You can do actual video conferencing with
patients. You can see the patients in their home.
We've got a lot of work that went into the research that went behind developing this,
that was by our ethnographers so that they could be used easily by patients
in their homes. So we've got a lot of different activities
that go on. This is through a broadband connection?
3G wireless and wired are for the video capability. And patients really love video conferencing.
They like it when you're talking to them, you know, they put their makeup on and all
that stuff before you call them so they look good.
But it actually will hold 30 days worth of biometric data, also on the device so that
patients can interact with it. Which is really good, and what we really want
to do with all of this is it's not just about a piece of equipment,
it's really about getting patients to change the way they function and helping clinicians
actually change their model of care so that this type of technology
fits in with it. It's the first cellular-enabled glucometer,
also we give back messages to the patient himself, so a physician
generated set of messages, so that at point of care, we're doing what the behavioral scientists
would say, a 'teaching moment.'
So we can change the way they behave, tell them take another unit if it's required, eat
more if they're blood's too low...Yeah, well it's more than a teaching
moment. It's also an intervention moment if needed.
That's right it's also a life-saving moment, right, right, and an intervention moment,
exactly. So we've seen about 25 very interesting companies
and one of my main frustrations as a physician is that we
reactively manage patients once they become unwell and as you can see many of these technologies
actually change that dynamic.
So let's treat them before they even become unwell.
We're seeing exciting technologies around diabetes, around heart failure, around a plethora
of other conditions. It's been a great start to the day and now
we're looking forward to the whole panel sessions, which are really
going to delve into the regulatory framework around this space.